Fujifilm Holdings Co., Ltd. in April 28, 2008 published the 2007 fiscal year (April 1, 2007 -2008 year on March 31) as well as the annual financial report for fiscal year 2008 sales expectations. For the fiscal year 2007 financial report shows that: to achieve sales of 24,750,000,000 U.S. dollars, representing a growth over the same period last year 2.3%; Operating profit 1,800,000,000 U.S. dollars, representing a substantial increase over the same period last year 83.4%.
Looking for the fiscal year 2007, global economic development of the situation, in the first half of the Japanese economy as a result of good corporate performance, fixed-asset investment to achieve steady growth in the second half of the price of crude oil and raw material prices and the yen’s appreciation and other factors, to Japan Economic recovery brought about by a number of shadow. The U.S. market by the second loan crisis, real estate investment and personal consumption slow down economic growth slightly in the doldrums; Europe as a result of the economic environment to improve employment and a steady rise further; Asian economies as a result of China’s leading role, are still high-speed development.
In this context, Fuji Photo Film for the fiscal year 2007 to increase the realization of the main reasons can be summed up as: 1, to medical products and services, printing with CTP plate (ComputerToPlate), LCD flat-panel display materials, mainly in the field of information products for sale A substantial amount of growth; 2, Digital Color MFP, such as global sales; 3, the yen fell against the euro exchange rate.
For these reasons and the fiscal year to focus on the implementation of the restructuring brought about by the effect of reducing fixed costs, although this fiscal year by the Bank and other major raw material prices remain high and as a result of depreciation of tangible fixed assets brought about by the revised accounting methods The increase in depreciation expenses and other factors, Fuji Photo Film’s operating profit still achieve a substantial increase in net profit last year was the 300%, to 900,000,000 U.S. dollars.
on expectations for the fiscal year 2008, Fuji Photo Film, said: Although there are times by the U.S. loan crisis, economic slowdown, the Japanese yen against the U.S. dollar exchange rate of increase in prices of raw materials, and other unfavorable factors, the Group remains confident in the new fiscal year to achieve 29,000,000,000 U.S. Million in sales and 21 billion dollars in operating profit, both to a new record high.
is based on the confidence in the field of information and documentation in the field of the cause of the rapid growth and structural transformation brought about by the reduction of fixed costs.
image of the cause of the fiscal year sales revenue of 4,760,000,000 U.S. dollars, although the cause of the areas of sales over the same period last year to reduce the 9.6%, but the rate of loss has been greatly reduced, only 020,000,000 U.S. dollars.
which, in the field of digital imaging, as a result of the first print shop and the popular photo book, consisting mainly of high value-added personalized digital imaging products are promoted, so that the color photographic paper Fujitsu’s market share has jumped to first in the world. In addition, with the January 2008 acquisition of IPLabsGmbh completed the online photo-processing services will further expand and upgrade the system.
digital cameras, with the second generation of facial recognition technology F50fd and the use of arc-line design of the new Fuji Z10fd, and other new digital cameras are a good reflection of the market, but still intense market competition, product price fell by a lot of pressure . In the future the company will focus on the performance of more color-rich S100FS and face recognition is more powerful F100fd, and other unique imaging technology with Fujitsu’s high-tech products as the center, to further expand Fuji digital camera sales.
in the field of traditional images, as a result of the popularity of digital cameras, traditional film market is still narrow, but as part of the industry to withdraw from the Fuji film market share is rising.
information on the cause of this fiscal year sales revenue of 9,640,000,000 U.S. dollars, over the same period last year to raise 8.0%; Operating profit 1,110,000,000 U.S. dollars, representing growth over the same period last year 33.9%. One,
health care / life sciences, computer diagnostic radiology devices (FCR) and dry film sales to maintain steady growth; IT sector in the process of really led the development of the Fuji medical imaging management system (Synapse) to expand sales; within Endoscopic products, although the industry is facing fierce competition, but Fuji nasal endoscopy technology such as the uniqueness of the product, overseas sales are still growing. In addition, as of Toyama Chemical Industry Co., Ltd. The acquisition, Fuji Photo Film from the original medical cause of the diagnosis and prevention in the area to further extend to cure in the field, so as to realize the full range of coverage in the field of medicine.
in the field of printing, with the expansion of demand in emerging countries and the popularity of computer-to-plate, Fuji Photo Film version of the timber sales are growing. In addition, the United Kingdom Fuji Photo Film X-Rite can be manufactured with superior resistance to climate change and the UV inks, solvents used in industrial ink-jet printers from April 2007 put the North American market, is gradually entering the market in Europe and Asia.
in the field of flat-panel liquid crystal display materials, liquid crystal display of a large number of demand-driven market, the Fuji film polarizers and the perspective of the film to expand sales. With the factory in Kyushu, Japan in March 2007 in the third production line in January 2008 and the fourth production line in operation, protective film polarizers and high-performance IPS-film production capacity has been greatly improved.
in the field of optical components, as a result of Fuji Photo Film AF? small zoom lens can be able to fully meet the component manufacturers of mobile phone camera phone camera light, small, high-quality requirements, sales increased significantly.
documents dealing with the cause of this fiscal year sales revenue of 10,360,000,000 U.S. dollars over the same period last year to raise 3.5%; Operating profit 750,000,000 U.S. dollars, representing an increase over the same period last year 41.6%.
to increase their gain is the main reason: 1, digital color MFP and print production system in the Asian market in China’s rapid growth in sales; 2, with an LED light source, such as new models of good sales; 3, to Customers improve business process consulting, document management and outsourcing services to help enterprises promote the internal governance of the global support services, such as services are expanded.
At present, Fuji Photo Film is in a second start stage. Group will focus on the medium-term business plan vision75 The strategy, launched in the following two key tasks to ensure growth, enhance the value of the enterprise.
1, to further promote the growth strategy in the cause of the focus on investment in the field;
2, for the realization of the tenacity and strong corporate structure, further SlimStrong activities, rapidly and decisively to control costs and promote the research and development cost effective使用.
In order to achieve the sustainable development of the Group, Fuji Photo Film must continue to foster growth and cause to break new ground. Group is actively digging their own unique diversified use of technology to create new value. As a concrete manifestation of the principle of one of the Fuji Photo Film in March this year acquired Toyama Chemical Industry Co., Ltd., entered the field of medicine. Toyama Chemical
excellent ability to develop new drugs and proprietary technology combined with Fujifilm’s unique nano-technology, will be cross-sectoral cooperation in the development of new drugs model , together with Fuji Photo Film in the capital, people and overseas sales networks, and many other strong investment Will certainly be able to speed up the pace of development of new drugs, the birth of a great synergy.
